Step-Ups in e-Health IPOs
This article was originally published in Start Up
Executive Summary
e-Health IPOs have been among the hottest IPOs available recently, fueled not only by Internet stock mania, but a genuine belief among experts that e-commerce will have a lasting impact on the health care industry. In this column, we examine the impressive valuation jumps made by recent Internet-related health care IPOs.
You may also be interested in...
Hope Springs Eternal in Biopharma IPO Pricing but Bad Haircuts Continue
While START-UP first noted an industry-wide tendency to overestimate the prices IPO investors were willing to pay in early 2005, IPOs have regularly fallen short of the anticipated price ever since, with few exceptions.
Biopharma VCs Move to the Middle in 2006
While the venture capital community spent roughly the same in biopharma investments in 2006 as they did in 2005, they put considerably more money into mid-stage companies (Series B and C investments), and slightly less into Series A and mezzanine rounds, than they had in 2005.
Biopharma IPOs Start Swing Back to Nasdaq
The trend of biopharma IPOs eschewing Nasdaq for European and other exchanges reverses modestly in 2006.